β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum.
E2F1
arrb1
granule cell precursors (GCPs)
medulloblastoma (MB)
neuronal stem cell (NSC)
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
07
2022
accepted:
17
02
2023
entrez:
16
3
2023
pubmed:
17
3
2023
medline:
17
3
2023
Statut:
epublish
Résumé
Development of the cerebellum is characterized by rapid proliferation of cerebellar granule cell precursors (GCPs) induced by paracrine stimulation of Sonic hedgehog (Shh) signaling from Purkinje cells, in the external granular layer (EGL). Then, granule cell precursors differentiate and migrate into the inner granular layer (IGL) of the cerebellum to form a terminally differentiated cell compartment. Aberrant activation of Sonic hedgehog signaling leads to granule cell precursors hyperproliferation and the onset of Sonic hedgehog medulloblastoma (MB), the most common embryonal brain tumor. β-arrestin1 (ARRB1) protein plays an important role downstream of Smoothened, a component of the Sonic hedgehog pathway. In the medulloblastoma context, β-arrestin1 is involved in a regulatory axis in association with the acetyltransferase P300, leading to the acetylated form of the transcription factor E2F1 (E2F1-ac) and redirecting its activity toward pro-apoptotic gene targets. This axis in the granule cell precursors physiological context has not been investigated yet. In this study, we demonstrate that β-arrestin1 has antiproliferative and pro-apoptotic functions in cerebellar development. β-arrestin1 silencing increases proliferation of Sonic hedgehog treated-cerebellar precursor cells while decreases the transcription of E2F1-ac pro-apoptotic targets genes, thus impairing apoptosis. Indeed, chromatin immunoprecipitation experiments show a direct interaction between β-arrestin1 and the promoter regions of the pro-apoptotic E2F1 target gene and
Identifiants
pubmed: 36923256
doi: 10.3389/fcell.2023.990711
pii: 990711
pmc: PMC10010392
doi:
Types de publication
Journal Article
Langues
eng
Pagination
990711Informations de copyright
Copyright © 2023 Abballe, Alfano, Antonacci, Cefalo, Cacchione, Del Baldo, Pezzullo, Po, Moretti, Mastronuzzi, De Smaele, Ferretti, Locatelli and Miele.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Science. 1999 Jan 29;283(5402):655-61
pubmed: 9924018
Dev Biol. 2004 Oct 15;274(2):233-44
pubmed: 15385155
Development. 2001 Oct;128(20):4011-20
pubmed: 11641224
J Clin Invest. 2006 Aug;116(8):2208-2217
pubmed: 16862215
J Neurosci. 2009 Dec 2;29(48):15161-8
pubmed: 19955368
Cerebellum. 2002 Jan-Mar;1(1):41-55
pubmed: 12879973
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Nat Rev Cancer. 2020 Jan;20(1):42-56
pubmed: 31819232
PLoS One. 2008 Aug 21;3(8):e3034
pubmed: 18716661
J Biol Chem. 2005 Feb 18;280(7):5693-702
pubmed: 15542599
Cell Cycle. 2010 Oct 1;9(19):4013-24
pubmed: 20935513
Mol Oncol. 2021 Feb;15(2):523-542
pubmed: 32920979
J Neurosci. 2007 Nov 14;27(46):12555-64
pubmed: 18003834
J Biol Chem. 2000 Aug 18;275(33):25358-64
pubmed: 10851232
Nat Rev Cancer. 2012 Dec;12(12):818-34
pubmed: 23175120
Oncogenesis. 2019 Nov 4;8(11):64
pubmed: 31685809
Nat Cell Biol. 2003 Jun;5(6):552-8
pubmed: 12766778
Genome Biol. 2006;7(9):236
pubmed: 17020596
Cancer Cell. 2012 May 15;21(5):601-613
pubmed: 22624711
Cancer Res. 2015 Mar 15;75(6):1009-20
pubmed: 25600647
Front Endocrinol (Lausanne). 2017 Mar 06;8:32
pubmed: 28321204
Neuron. 1999 Jan;22(1):103-14
pubmed: 10027293
J Cell Sci. 2007 Jan 15;120(Pt 2):213-8
pubmed: 17215450
Curr Biol. 1999 Nov 18;9(22):1304-14
pubmed: 10574760
J Neurosci. 2005 Sep 7;25(36):8338-46
pubmed: 16148242
Science. 2005 Apr 22;308(5721):512-7
pubmed: 15845844
Science. 2008 Jun 27;320(5884):1777-81
pubmed: 18497258
Cancer Cell. 2008 Aug 12;14(2):135-45
pubmed: 18691548
Nat Rev Neurosci. 2002 Jan;3(1):24-33
pubmed: 11823802
J Neurochem. 2010 Apr;113(2):329-40
pubmed: 20050979
EMBO J. 2010 Aug 4;29(15):2646-58
pubmed: 20581804
Stem Cells Int. 2017;2017:5274171
pubmed: 28298929
Cancer Cell. 2009 Mar 3;15(3):184-94
pubmed: 19249677
J Natl Cancer Inst. 2011 Feb 16;103(4):317-33
pubmed: 21212384
Front Endocrinol (Lausanne). 2017 Nov 10;8:311
pubmed: 29176962
Cell. 2005 Dec 2;123(5):833-47
pubmed: 16325578
Nat Neurosci. 2005 Jun;8(6):723-9
pubmed: 15908947
EMBO J. 2008 Oct 8;27(19):2616-27
pubmed: 18756266
Br J Cancer. 2014 Jul 29;111(3):568-76
pubmed: 24937675
In Vitro Cell Dev Biol Anim. 2011 Aug;47(7):492-9
pubmed: 21614651